Related Experiment Video
Updated: Jan 19, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages
Tzanko S Stantchev1, Autumn Zack-Taylor2, Nicholas Mattson3
1Division of Biotechnology Review and Research 1 (DBRR1), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. tzanko.stantchev@fda.hhs.gov.
Abstract:
Macrophages are one of the first and also a major site of filovirus replication and, in addition, are a source of multiple cytokines, presumed to play a critical role in the pathogenesis of the viral infection. Some of these cytokines are known to induce macrophage phenotypic changes in vitro, but how macrophage polarization may affect the cell susceptibility to filovirus entry remains largely unstudied. We generated different macrophage subsets using cytokine pre-treatment and subsequently tested their ability to fuse with beta-lactamase containing virus-like particles (VLP), pseudotyped with the surface glycoprotein of Ebola virus (EBOV) or the glycoproteins of other clinically relevant filovirus species. We found that pre-incubation of primary human monocyte-derived macrophages (MDM) with interleukin-10 (IL-10) significantly enhanced filovirus entry into cells obtained from multiple healthy donors, and the IL-10 effect was preserved in the presence of pro-inflammatory cytokines found to be elevated during EBOV disease. In contrast, fusion of IL-10-treated macrophages with influenza hemagglutinin/neuraminidase pseudotyped VLPs was unchanged or slightly reduced. Importantly, our in vitro data showing enhanced virus entry are consistent with the correlation established between elevated serum IL-10 and increased mortality in filovirus infected patients and also reveal a novel mechanism that may account for the IL-10-mediated increase in filovirus pathogenicity.
Insights
Interleukin-10 (IL-10) enhances filovirus entry into macrophages, increasing susceptibility to infection. This finding explains how IL-10 contributes to severe filovirus disease and mortality in patients.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Macrophages are key targets for filovirus replication and cytokine production, influencing disease pathogenesis.
- The impact of macrophage polarization on filovirus entry susceptibility is not well understood.
Purpose of the Study:
- To investigate how macrophage polarization affects susceptibility to filovirus entry.
- To determine the role of interleukin-10 (IL-10) in modulating macrophage entry of filoviruses.
Main Methods:
- Generated distinct macrophage subsets via cytokine pre-treatment.
- Assessed fusion of these macrophages with virus-like particles (VLPs) pseudotyped with filovirus glycoproteins (e.g., Ebola virus).
- Evaluated IL-10's effect on VLP fusion in the presence of pro-inflammatory cytokines.
Main Results:
- Pre-incubation with IL-10 significantly enhanced filovirus entry into primary human monocyte-derived macrophages (MDM).
- This IL-10-mediated enhancement was observed across multiple healthy donors and persisted with pro-inflammatory cytokines.
- IL-10 did not enhance, and slightly reduced, entry of influenza virus-pseudotyped VLPs, indicating specificity.
Conclusions:
- IL-10 promotes filovirus entry into macrophages, offering a novel mechanism for increased pathogenicity.
- Findings align with clinical observations linking elevated IL-10 to higher mortality in filovirus infections.
- Macrophage polarization by IL-10 is a critical factor in filovirus disease progression.

